Neuca (LTS:0MJR) Total Operating Expense: zł1,279 Mil (TTM As of Mar. 2026)


LTS:0MJR Neuca SA LTS:0MJR
95 GF Score
Price zł760.00
GF Value zł952.03
! 4 Warning Signs
View Full Analysis

What is Neuca Total Operating Expense?

Neuca LTS:0MJR 95 Total Operating Expense is zł1,279 Mil as of Mar. 2026. GuruFocus rates LTS:0MJR with a GF Score™ of 95/100 and a GF Value™ of zł952.03. The stock has 4 warning signs investors should review.

Neuca's Total Operating Expense for the three months ended in Mar. 2026 was zł327 Mil. Neuca's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was zł1,279 Mil.

Neuca Total Operating Expense Related Terms

Neuca Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Neuca's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca Total Operating Expense Chart

Neuca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 769.17 869.91 1,036.68 1,136.05 1,262.04

Neuca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 309.96 327.35 321.89 302.84 327.15
LTS:0MJR
95GF Score
Neuca SA LTS:0MJR
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuca Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł1,279 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of zł1,279 Mil mean?
Neuca (LTS:0MJR) has a Total Operating Expense of zł1,279 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Neuca and its competitors.
Is Neuca's Total Operating Expense too high?
Neuca's current Total Operating Expense is zł1,279 Mil. Overall, Neuca has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's Total Operating Expense compare to MCK and CAH?
Neuca's Total Operating Expense of zł1,279 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Distribution company?
A good Total Operating Expense depends on the Medical Distribution industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Neuca and its competitors. Neuca's current Total Operating Expense is zł1,279 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (LTS:0MJR) has a current Total Operating Expense of zł1,279 Mil. The stock's GF Value™ is zł952.03, compared to a current price of zł760.00 — trading 20.2% below its estimated fair value. The current Total Operating Expense is zł1,279 Mil. Neuca's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Neuca (LTS:0MJR), the current Total Operating Expense is zł1,279 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (LTS:0MJR) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of zł760.00 is trading 20.2% below its estimated GF Value™ of zł952.03.

Key valuation signals for LTS:0MJR:

  • Total Operating Expense: zł1,279 Mil
  • GF Value™: zł952.03 vs. price of zł760.00 (20.2% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the LTS:0MJR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuca Business Description

Other Exchanges NEU:Poland
Address ul. Forteczna 35‑37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
95GF Score

Get the complete analysis for LTS:0MJR

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł760.00
Price
zł952.03
GF Value